Fiercebiotech
Published November 17, 2026
CG preps new, expanded bladder cancer plans with FDA after ph. 3 win - Fierce Biotech
Read the full story at Fiercebiotech
Fierce Biotech at London Life Sciences Week. The Savoy ... Helus' chemically modified psychedelic hits key goals in phase 3 depression trial.
Surfaced by this Google Alert
- Psychedelic biotech